
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270204
DTEND;VALUE=DATE:20270208
DTSTAMP:20261017T143719Z
CREATED:20261017T143719Z
LAST-MODIFIED:20261017T143719Z
UID:10001112-1801699200-1802044799@oncodaily.com
SUMMARY:EHA-EBMT 9th European CAR T-cell Meeting
DESCRIPTION:The EHA-EBMT 9th European CAR T-cell Meeting will take place from February 4–6\, 2027\, at the Centro de Congressos de Lisboa in Lisbon\, Portugal. \nJointly organized by the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EBMT)\, the three-day in-person meeting will bring together clinicians\, scientists\, nurses\, industry representatives\, patient advocates\, and other professionals involved in CAR T-cell therapy. \nThe meeting will explore the rapidly evolving CAR T-cell landscape\, from clinical successes and emerging indications to the remaining challenges surrounding manufacturing\, delivery\, toxicity management\, long-term safety\, and durable efficacy. The programme will feature scientific advances\, clinical updates\, real-world applications\, and opportunities for multidisciplinary discussion and collaboration. \nParticular attention will be given to CAR T-cell efficacy and toxicity\, biomarkers and prediction models\, innovative T-cell engineering\, CAR design and optimization\, manufacturing methodologies\, mechanisms of treatment response and resistance\, and the management of early and late toxicities.
URL:https://oncodaily.com/event/eha-ebmt-610432
LOCATION:Centro de Congressos de Lisboa (CCL)\, Praça das Indústrias 1\, Lisbon\, Lisbon District\, 1300-307\, Portugal
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/CART27_Banner_1600x900px-2-512x288-1.webp
END:VEVENT
END:VCALENDAR